Efficacy of Low-Dose Tocilizumab on a Relapse of Adult-Onset Still’s Disease
Still’s disease is an inflammatory disorder of unknown etiology. First-line therapy is based on corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) but the frequency of relapses and corticosteroid-induced adverse events are limiting factors. The efficacy of intravenous tocilizumab (TC...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karolinum Press
2016-04-01
|
| Series: | Acta Medica |
| Subjects: |